source
- Medicare’s new $50 GLP‑1 weight‑loss drug program may create barriers for patients, warns expertsMedicare has launched a program that caps out‑of‑pocket costs for GLP‑1 weight‑loss medicines such as Wegovy, Zepbound and Foundayo at $50 a month for eligible beneficiaries. The initiative is inte…
- Trump’s vaccine executive order likely erodes public trust, says epidemiologistPresident Trump signed an executive order that claims to restore confidence in childhood vaccines by scaling back state mandates and trimming the recommended schedule from 18 diseases to 11. The o…